KCER Release Date: September 29, 2021

One Lot of GLUCAGON Emergency Kit by Eli Lilly: Recall - Due to Loss of Potency

September 16, 2021:

Enforcement Policy for Face Masks, Barrier Face Coverings, Face Shields, Surgical Masks, and Respirators During the Coronavirus Disease (COVID-19) Public Health Emergency (Revised)

July 9, 2021

Lyra SARS-CoV-2 Assay (M120) by Quidel: Class I Recall - Due to Risk of False Negative Results

Company Announcement

May 24, 2021

The following quote is attributed to Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research:

April 19, 2021

Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Monoclonal Antibody Bamlanivimab

As of April 12, 2021, approximately 6.85 million doses of the Johnson & Johnson (J&J) COVID-19 vaccine (Janssen) have been administered in the United States. The Centers for Disease Control and Prevention (CDC) and the U.S.